BR9815219A - Uso de tiazolidinedionas para o tratamento da hiperglicemia - Google Patents

Uso de tiazolidinedionas para o tratamento da hiperglicemia

Info

Publication number
BR9815219A
BR9815219A BR9815219-0A BR9815219A BR9815219A BR 9815219 A BR9815219 A BR 9815219A BR 9815219 A BR9815219 A BR 9815219A BR 9815219 A BR9815219 A BR 9815219A
Authority
BR
Brazil
Prior art keywords
treatment
hyperglycemia
thiazolidinediones
thiazolidinedions
mammal
Prior art date
Application number
BR9815219-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Robin Edwing Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9815219A publication Critical patent/BR9815219A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BR9815219-0A 1997-10-13 1998-10-12 Uso de tiazolidinedionas para o tratamento da hiperglicemia BR9815219A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (1)

Publication Number Publication Date
BR9815219A true BR9815219A (pt) 2001-01-02

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815219-0A BR9815219A (pt) 1997-10-13 1998-10-12 Uso de tiazolidinedionas para o tratamento da hiperglicemia

Country Status (24)

Country Link
EP (1) EP1023056A1 (xx)
JP (1) JP2001519382A (xx)
KR (1) KR20010024481A (xx)
CN (1) CN1281359A (xx)
AP (1) AP2000001787A0 (xx)
AU (1) AU9547098A (xx)
BG (1) BG104404A (xx)
BR (1) BR9815219A (xx)
CA (1) CA2306086A1 (xx)
CZ (1) CZ20001297A3 (xx)
EA (1) EA002659B1 (xx)
GB (1) GB9721693D0 (xx)
HR (1) HRP20000255A2 (xx)
HU (1) HUP0003922A3 (xx)
ID (1) ID24521A (xx)
IL (1) IL135513A0 (xx)
NO (1) NO20001898L (xx)
NZ (1) NZ503862A (xx)
OA (1) OA11683A (xx)
PL (1) PL339813A1 (xx)
SK (1) SK5312000A3 (xx)
TR (1) TR200000958T2 (xx)
WO (1) WO1999018943A1 (xx)
YU (1) YU28800A (xx)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
JP2001519382A (ja) 2001-10-23
IL135513A0 (en) 2001-05-20
OA11683A (en) 2005-01-12
AU9547098A (en) 1999-05-03
CN1281359A (zh) 2001-01-24
HUP0003922A3 (en) 2001-12-28
AP2000001787A0 (en) 2000-06-30
GB9721693D0 (en) 1997-12-10
WO1999018943A1 (en) 1999-04-22
EA200000419A1 (ru) 2000-10-30
CA2306086A1 (en) 1999-04-22
BG104404A (bg) 2000-12-29
YU28800A (sh) 2003-02-28
CZ20001297A3 (cs) 2001-08-15
KR20010024481A (ko) 2001-03-26
NZ503862A (en) 2003-01-31
EP1023056A1 (en) 2000-08-02
PL339813A1 (en) 2001-01-02
NO20001898L (no) 2000-06-09
TR200000958T2 (tr) 2000-08-21
ID24521A (id) 2000-07-20
EA002659B1 (ru) 2002-08-29
SK5312000A3 (en) 2000-09-12
NO20001898D0 (no) 2000-04-12
HUP0003922A2 (hu) 2001-10-28
HRP20000255A2 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
BR9911656A (pt) Composição farmacêutica, processos para prevenção ou tratamento de diabetes em um mamìfero, para prevenção ou tratamento de complicações diabéticas em um mamìfero e para prevenção ou tratamento da tolerância a glicose prejudicada em um mamìfero, uso de um sensibilizador de insulina, e, proceso para reduzir os efeitos colaterais de um sensibilizador de insulina ou/ e um anorético administrado a um mamìfero diabético
NO20090846L (no) Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav
NO994706L (no) Farmasöytisk blanding for oraladministrering av et N-piperidino-3-pyrazolkarboksyamidderivat, samt salter og solvater derav
KR960000924A (ko) 인슐린 유사체 배합물
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
BR9911112A (pt) Petpìdeo-1 semelhante a glucagon aperfeiçoa aresposta de ß-células à glicose em pacientes comtolerância à glicose prejudicada
NO944803L (no) Farmasöytisk preparat for kontrollert frigivelse
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
BR9810445A (pt) Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e diguanida
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
CY1107745T1 (el) Αγωγη του διαβητη με θειαζολιδινοδιονη και σουλφονυλουρια
BR9810444A (pt) Tratamento de diabete com rosiglitazona e insulina
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
ES2196167T3 (es) Composicion farmaceutica que contiene propionato de 3-(2,2,2-trimetilhidrazinio) y gamma-butirobetaina para el tratamiento de enfermedades cardiovasculares.
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
US6589995B2 (en) Method of inhibiting pancreatic β-cell p135 O-glycosylation
BR9810292A (pt) Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e inibidor de alfa-glicosidase
BR9810186A (pt) Tratamento de diabete com tiazolidinadiona e inibidor de alfa-glicosidade
BR9815220A (pt) Uso de tiazolidinedionas para o tratamento da hiperglicemia
BR9815219A (pt) Uso de tiazolidinedionas para o tratamento da hiperglicemia
AU8019898A (en) Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
BR9915214A (pt) Combinações contendo um beta-agonista e umagente anti-diabético adicional
AR008025A1 (es) Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.